Theratechnologies, Merck KGaA sales and marketing update

Theratechnologies said it sent a first shipment of 1 mg Egrifta tesamorelin to its U.S. distributor and that the analog of growth hormone-releasing factor will be available in the U.S. by mid-Septem...